Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Small Cell Lung Carcinoma × Drug Therapy × Clear all

Phase

Phase 2 12 Phase NA 2 Phase 2/3 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 11 Neoplasms 9 Pancreatic Neoplasms 7 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Lung Neoplasms 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Glioblastoma 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Head and Neck Neoplasms 4 Central Nervous System Neoplasms 4 Brain Neoplasms 4 Recurrence 3 Neuroblastoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma 3 Gliosarcoma 3 Fallopian Tube Neoplasms 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Astrocytoma 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Mesothelioma, Malignant 2 Kidney Neoplasms 2 Gastrointestinal Neoplasms 2 Esophageal Squamous Cell Carcinoma 2

Interventions

Cisplatin 19 Etoposide 17 Carboplatin 16 Topotecan 12 durvalumab 10 Irinotecan 9 pembrolizumab 8 Paclitaxel 7 Nivolumab 7 tremelimumab 6 atezolizumab 6 Radiotherapy 6 Gemcitabine 6 Docetaxel 6 rovalpituzumab tesirine 4 budigalimab 4 Specimen Handling 4 Pemetrexed 4 Ipilimumab 4 Doxorubicin 4 Cyclophosphamide 4 Bortezomib 4 venetoclax 3 talazoparib 3 olaparib 3 Platinum 3 Magnetic Resonance Spectroscopy 3 Leucovorin 3 Injections 3 Fluorouracil 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03971214 2019-06-04

PICARES

ChineseAMS

Phase 1 Unknown

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡